Daniel, Jacinta .
HRN: 02-18-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/15/2025
COTRIMOXAZOLE 960MG (TAB)
11/15/2025
11/22/2025
PO
960mg
Q6h
S. Kloosi Infection
Waiting Final Action
Indication: Culture-directed Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes